Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Neurology and Therapy|May 12, 2023
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database AnalysisColin Anderson-Smits, Mary E Ritchey, Zhongwen Huang, et al.Neurology and Therapy|May 6, 2026
Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice ExperimentMin Yang, Miriam L Zichlin, Chelsey Fix, et al.Journal of Clinical Medicine|February 26, 2025
Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature ReviewMaria Dimou, Angelo Vacca, Silvia Sánchez-Ramón, et al.Advances in Hematology|December 29, 2025
Multiple Myeloma and Secondary Immunodeficiency: A Retrospective Database Analysis Assessing Burden of Infection and Treatment PatternsCsaba Siffel, Matthew S Davids, Colin Anderson-Smits, et al.Pharmacoepidemiology and Drug Safety|March 17, 2025
A Comparative Real-World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating PolyradiculoneuropathyJ Bradley Layton, Colin Anderson-Smits, Zhongwen Huang, et al.Clinical Lymphoma, Myeloma & Leukemia|May 11, 2024
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell MalignancyJoshua Richter, Matthew S Davids, Colin Anderson-Smits, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Early Diagnosis of Primary Immunodeficiency Disease Using Clinical Data and Machine LearningAnoop Mayampurath, Aswathy Ajith, Colin Anderson-Smits, et al.AIDS and Behavior|April 13, 2011
Patterns and predictors of HIV/STI risk among Latino migrant men in a new receiving communityPatricia Kissinger, Stephanie Kovacs, Colin Anderson-Smits, et al.Journal of the Peripheral Nervous System : JPNS|November 11, 2024
Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trialRobert D M Hadden, Henning Andersen, Vera Bril, et al.Pharmacoepidemiology and Drug Safety|March 3, 2025
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims DataJoshua U Okonkwo, Erika K Williams, Reza Sadjadi, et al.Pageof 3